Identification of the platelet-specific alloantigen, Naka, on platelet membrane glycoprotein IV.

Abstract:

:We describe the membrane localization of a new platelet-specific alloantigen, designated Naka, that is involved in refractoriness to HLA-matched platelet transfusions. By indirect immunoprecipitation, anti-Naka antibody precipitated a single, radiolabeled platelet membrane protein with a molecular weight (mol wt) of 91 Kd from Naka-positive platelets. When radiolabeled Naka-negative platelets were used as a source of target antigens, no radiolabeled proteins were precipitated. The analyses using nonreduced-reduced two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and using rabbit antiglycoprotein (GP)IV demonstrated that this protein corresponds to GPIV (alternatively GPIIIb). Furthermore, in dot immunobinding, anti-Naka antibody bound to purified GPIV. Our results provide definitive evidence that the Naka alloantigen is carried on GPIV. These results also demonstrate that, on occasion, antibodies against GPIV may play an important role in refractoriness to platelet transfusions.

journal_name

Blood

journal_title

Blood

authors

Tomiyama Y,Take H,Ikeda H,Mitani T,Furubayashi T,Mizutani H,Yamamoto N,Tandon NN,Sekiguchi S,Jamieson GA

subject

Has Abstract,Author List Incomplete

pub_date

1990-02-01 00:00:00

pages

684-7

issue

3

eissn

0006-4971

issn

1528-0020

journal_volume

75

pub_type

杂志文章

相关文献

BLOOD文献大全
  • p53 abnormalities in splenic lymphoma with villous lymphocytes.

    abstract::The incidence and role of p53 abnormalities have not been reported in splenic lymphoma with villous lymphocytes (SLVL), the leukemic counterpart of splenic marginal zone lymphoma. Because p53 abnormalities correlate with progressive and refractory disease in cancer and isochromosome 17q has been described in SLVL, a l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.11.3552

    authors: Gruszka-Westwood AM,Hamoudi RA,Matutes E,Tuset E,Catovsky D

    更新日期:2001-06-01 00:00:00

  • Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.

    abstract::Mast cells may be cultured from human peripheral blood in the presence of recombinant human stem cell factor (rhSCF). The characteristics of the cells in peripheral blood that give rise to mast cells are unknown. Because mast cell precursors in human marrow are CD34+, human peripheral blood mononuclear cells from pati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rottem M,Okada T,Goff JP,Metcalfe DD

    更新日期:1994-10-15 00:00:00

  • Diacylglycerol generation in fluoride-treated neutrophils: involvement of phospholipase D.

    abstract::Neutrophils exposed to fluoride ion (F-) respond with a delayed and sustained burst of superoxide anion release that is both preceded by and dependent on the influx of Ca2+ from the extracellular medium. The results of this study demonstrate a similarly delayed and sustained generation of 1,2-diglyceride in F(-)-treat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: English D,Taylor G,Garcia JG

    更新日期:1991-06-15 00:00:00

  • High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.

    abstract::We treated 5 patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome and multifocal bone lesions or diffuse bone marrow plasmacytic infiltration with high-dose therapy (HDT) and autologous blood stem cell transplantation. In all cases, the treatment produced...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood.v99.8.3057

    authors: Jaccard A,Royer B,Bordessoule D,Brouet JC,Fermand JP

    更新日期:2002-04-15 00:00:00

  • The osmotic fragility of erythrocytes after prolonged liquid storage and after reinfusion.

    abstract::Although it is recognized that red cells lose membrane during storage, estimation of the osmotic fragility of erythrocytes has not previously proven to be a useful measurement of the storage lesion. Erythrocytes from blood stored in CPD-A2 were found to have a markedly increased osmotic fragility. A major portion of t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Beutler E,Kuhl W,West C

    更新日期:1982-06-01 00:00:00

  • Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.

    abstract::Exposure to HIV-1 does not necessarily result in infection and progression toward disease, thus suggesting that the control of viral infection may be achieved. Antibodies to CCR5 have been detected in HIV-exposed but uninfected subjects (ESNs); thus, these antibodies could be involved in HIV protection. To assess whet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2463

    authors: Pastori C,Weiser B,Barassi C,Uberti-Foppa C,Ghezzi S,Longhi R,Calori G,Burger H,Kemal K,Poli G,Lazzarin A,Lopalco L

    更新日期:2006-06-15 00:00:00

  • Activation peptides prolong the murine plasma half-life of human factor VII.

    abstract::Coagulation factors VII (FVII), IX (FIX), X (FX), and protein C share the same domain organization but display very different plasma half-lives. It is plausible that the half-life is influenced by the activation peptide, differing in length and glycosylation and missing in FVII. To test this hypothesis, the influence ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-06-290098

    authors: Johansson L,Karpf DM,Hansen L,Pelzer H,Persson E

    更新日期:2011-03-24 00:00:00

  • Potentiation of the erythropoietin response by dimethyl sulfoxide priming of erythroleukemia cells: evidence for interaction of two signaling pathways.

    abstract::Erythropoietin (Epo) and dimethyl sulfoxide (DMSO) are believed to induce the differentiation of transformed erythroid cells by different signal transduction pathways. We have now obtained evidence for the interaction of these pathways. We used a Rauscher murine erythroleukemia cell line with a relatively low (8% to 1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chern Y,Yonekura S,Sytkowski AJ

    更新日期:1990-12-01 00:00:00

  • MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells.

    abstract::Best known for presenting antigenic peptides to CD4+ T cells, major histocompatibility complex class II (MHC II) also transmits or may modify intracellular signals. Here, we show that MHC II cell-autonomously regulates the balance between self-renewal and differentiation in B-cell precursors, as well as in malignant B...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-11-885467

    authors: Merkenschlager J,Eksmond U,Danelli L,Attig J,Young GR,Nowosad C,Tolar P,Kassiotis G

    更新日期:2019-03-07 00:00:00

  • Identification of CD8alpha+CD11c- lineage phenotype-negative cells in the spleen as committed precursor of CD8alpha+ dendritic cells.

    abstract::CD8alpha+ dendritic cells (DCs) represent a functionally distinct DC subset in vivo, which plays a critical role in initiating various cellular immune responses. However, the committed precursor of CD8alpha+ DCs remains to be identified. We reported here that murine splenic CD8alpha+CD11c- lineage phenotype (Lin)- cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.2.569

    authors: Wang Y,Zhang Y,Yoneyama H,Onai N,Sato T,Matsushima K

    更新日期:2002-07-15 00:00:00

  • Inhibition of ristocetin-induced platelet agglutination by vancomycin.

    abstract::Ristocetin and vancomycin are structurally similar glycopeptide antibiotics. Both vancomycin and ristocetin in high concentrations (3.0 mg/ml) cause the precipitation of fibrinogen, plasminogen, and IgG from platelet-poor plasma (PPP). In contrast to ristocetin, vanomycin (0.5-1.5 mg/ml) does not agglutinate platelets...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Moake JL,Cimo PL,Peterson DM,Roper P,Natelson EA

    更新日期:1977-09-01 00:00:00

  • A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.

    abstract::BB-10010 is a variant of the human form of macrophage inflammatory protein-1alpha (MIP-1alpha), which has been shown in mice to block the entry of hematopoietic stem cells into S-phase and to increase their self-renewal capacity during recovery from cytotoxic damage. Its use may constitute a novel approach for protect...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Clemons MJ,Marshall E,Dürig J,Watanabe K,Howell A,Miles D,Earl H,Kiernan J,Griffiths A,Towlson K,DeTakats P,Testa NG,Dougal M,Hunter MG,Wood LM,Czaplewski LG,Millar A,Dexter TM,Lord BI

    更新日期:1998-09-01 00:00:00

  • Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(-) bone marrow progenitor cells: synergism with non-alloreactive (host x donor)F(1) T cells.

    abstract::Induction of transplantation tolerance by means of bone marrow (BM) transplantation could become a reality if it was possible to achieve engraftment of hematopoietic stem cells under nonlethal preparatory cytoreduction of the recipient. To that end, BM facilitating cells, veto cells, or other tolerance-inducing cells,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bachar-Lustig E,Li HW,Gur H,Krauthgamer R,Marcus H,Reisner Y

    更新日期:1999-11-01 00:00:00

  • IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.

    abstract::Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are associated with disease-initiating stem cells that are not eliminated by conventional therapies. Novel therapeutic targets against preleukemic stem cells need to be identified for potentially curative strategies. We conducted parallel transcriptional...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-621631

    authors: Schinke C,Giricz O,Li W,Shastri A,Gordon S,Barreyro L,Bhagat T,Bhattacharyya S,Ramachandra N,Bartenstein M,Pellagatti A,Boultwood J,Wickrema A,Yu Y,Will B,Wei S,Steidl U,Verma A

    更新日期:2015-05-14 00:00:00

  • Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins.

    abstract::We have applied a proteomics approach to analyze signaling cascades in human platelets stimulated by thrombin receptor activating peptide (TRAP). By analyzing basal and TRAP-activated platelets using 2-dimensional gel electrophoresis (2-DE), we detected 62 differentially regulated protein features. From these, 41 coul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2392

    authors: García A,Prabhakar S,Hughan S,Anderson TW,Brock CJ,Pearce AC,Dwek RA,Watson SP,Hebestreit HF,Zitzmann N

    更新日期:2004-03-15 00:00:00

  • Genetic variation responsible for mouse strain differences in integrin alpha 2 expression is associated with altered platelet responses to collagen.

    abstract::As mouse models have become commonplace for studying hemostasis and thrombosis, we considered whether the mouse system had utility for assessing genetic alterations in platelet receptors. Platelets from 5 mouse strains (C57BL/6 [C57], FVB/N [FVB], BALB/c, C3H/He, and 129Sv) showed only minor differences in the express...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-10-3721

    authors: Li TT,Larrucea S,Souza S,Leal SM,López JA,Rubin EM,Nieswandt B,Bray PF

    更新日期:2004-05-01 00:00:00

  • Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells.

    abstract::The mouse Pim-1 gene encodes two cytoplasmic serine-threonine-specific protein kinases. The gene has been found to be activated (overexpressed) by retroviral insertion in hematopoietic tumors in mice. Transgenic mice that overexpress Pim-1 (E mu-Pim-1) have a low incidence of spontaneous T-cell lymphomas and an increa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Domen J,van der Lugt NM,Laird PW,Saris CJ,Clarke AR,Hooper ML,Berns A

    更新日期:1993-09-01 00:00:00

  • Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia.

    abstract::Derivative chromosome 9 deletions are seen in 10% to 15% of patients with chronic myelogenous leukemia and have been associated with a poor prognosis; however, no studies have been performed in the context of a randomized clinical trial. We developed a DNA-based deletion screen and investigated 339 chronic phase patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-074252

    authors: Kreil S,Pfirrmann M,Haferlach C,Waghorn K,Chase A,Hehlmann R,Reiter A,Hochhaus A,Cross NC,German Chronic Myelogenous Leukemia (CML) Study Group.

    更新日期:2007-08-15 00:00:00

  • Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia.

    abstract::The purpose of this study was to define, in a phase I study in leukemia, the maximally tolerated dose (MTD), major toxicities, and possible antitumor activity of Topotecan, a new topoisomerase I (topo I) inhibitor. Topotecan was delivered by a 5-day continuous infusion every 3 to 4 weeks to patients with refractory or...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Kantarjian HM,Beran M,Ellis A,Zwelling L,O'Brien S,Cazenave L,Koller C,Rios MB,Plunkett W,Keating MJ

    更新日期:1993-03-01 00:00:00

  • The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation.

    abstract::Despite matching for serologically defined HLA-A, B, DR antigens, acute graft-versus-host disease (GVHD) is a major complication contributing to increased morbidity and mortality in patients who undergo marrow transplantation from unrelated donors. The extent to which unrecognized mismatching for alleles that encode D...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Petersdorf EW,Longton GM,Anasetti C,Martin PJ,Mickelson EM,Smith AG,Hansen JA

    更新日期:1995-08-15 00:00:00

  • Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A.

    abstract::Neuropilin-1 (Npn-1) is a receptor shared by class 3 semaphorins and heparin-binding forms of vascular endothelial growth factor (VEGF), protein families that regulate endothelial and neuronal-cell function. Ligand interaction with Npn-1 dictates the choice of signal transducer; plexins transduce semaphorin signals, a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4113

    authors: Narazaki M,Tosato G

    更新日期:2006-05-15 00:00:00

  • Determination of platelet antigens and glycoproteins in the human fetus.

    abstract::The autosomal recessive transmission of Glanzmann's thrombasthenia (GT) and Bernard-Soulier syndrome (BSS), together with requests of families who already had children with these diseases, prompted us to investigate the feasibility of their antenatal diagnosis. The preliminary step leading to the early detection of GT...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gruel Y,Boizard B,Daffos F,Forestier F,Caen J,Wautier JL

    更新日期:1986-08-01 00:00:00

  • Coexistence of multiple mechanisms of PT523 resistance in human leukemia cells harboring 3 reduced folate carrier alleles: transcriptional silencing, inactivating mutations, and allele loss.

    abstract::The reduced folate carrier (RFC) is the dominant route for the uptake of various antifolates including PT523, a potent dihydrofolate reductase inhibitor (Ki = 0.35 pM) and an excellent transport substrate of the RFC (Kt = 0.7 microM). Here, we describe the multiple mechanisms of RFC inactivation in human leukemia PT52...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4048

    authors: Kaufman Y,Ifergan I,Rothem L,Jansen G,Assaraf YG

    更新日期:2006-04-15 00:00:00

  • Downregulation of the anti-HLA alloimmune response by variable region-reactive (anti-idiotypic) antibodies in leukemic patients transfused with platelet concentrates.

    abstract::Approximately 30% to 40% of patients with acute leukemia receiving repeated pooled random-donor platelet transfusions develop anti-HLA alloantibodies. Over time, however, serum anti-HLA concentrations decrease in approximately 50% of these patients, despite continued exposure to platelet and/or red blood cell transfus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Atlas E,Freedman J,Blanchette V,Kazatchkine MD,Semple JW

    更新日期:1993-01-15 00:00:00

  • Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations.

    abstract::Venomous snakes produce an array of toxic compounds, including procoagulants to defend themselves and incapacitate prey. The Australian snake Pseudonaja textilis has a venom-derived prothrombin activator homologous to coagulation factors V (FV) and Xa (FXa). Here we show that the FV component (pt-FV) has unique biolog...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-202663

    authors: Bos MH,Boltz M,St Pierre L,Masci PP,de Jersey J,Lavin MF,Camire RM

    更新日期:2009-07-16 00:00:00

  • Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor.

    abstract::The most abundant intracellular proteins, heat shock proteins (HSPs), serve as molecular chaperones for regulatory and maturation pathways. Diverse families of HSPs have been shown to bind antigenic peptides and to play major roles in innate and adaptive immune responses through the common HSP receptor, CD91. HIV-1+ p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-03-0891

    authors: Stebbing J,Gazzard B,Portsmouth S,Gotch F,Kim L,Bower M,Mandalia S,Binder R,Srivastava P,Patterson S

    更新日期:2003-09-01 00:00:00

  • Superficial venous thrombosis: recognizing the risk.

    abstract::In this issue of Blood, Roach and colleagues show that individuals with prior superficial venous thrombosis are at increased risk of developing venous thromboembolism when exposed to acquired clinical risk factors. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2013-11-537019

    authors: Bates SM

    更新日期:2013-12-19 00:00:00

  • Chronic T cell leukemia with unusual cellular characteristics in ataxia telangiectasia.

    abstract::A 27-year-old male patient with ataxia telangiectasia (AT) developed atypical chronic lymphocytic leukemia with increasing bone marrow infiltration in the absence of organomegaly. One-third of the leukemia cells expressed a mature suppressor/cytotoxic T cell phenotype (T3+ T4- T6- T8+ T10-), two-thirds demonstrated ad...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dührsen U,Uppenkamp M,Uppenkamp I,Becher R,Engelhard M,König E,Meusers P,Meuer S,Brittinger G

    更新日期:1986-08-01 00:00:00

  • Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

    abstract::The t(11;14)(q13;q32) results in up-regulation of cyclin D1 and is the most common translocation detected in multiple myeloma, where it is also associated with a lymphoplasmacytic morphology. We performed an interphase fluorescent in situ hybridization (FISH) study to determine the clinical and biologic significance o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3735

    authors: Fonseca R,Blood EA,Oken MM,Kyle RA,Dewald GW,Bailey RJ,Van Wier SA,Henderson KJ,Hoyer JD,Harrington D,Kay NE,Van Ness B,Greipp PR

    更新日期:2002-05-15 00:00:00

  • Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma.

    abstract::Cytokine gene-modified tumor cells have increased immunogenicity and retain the antigenic repertoire of a particular neoplasia. However, practical concerns have led to an increased interest in allogeneic gene-transduced bystander cells as a broader source of cytokines for autologous tumor cell-based vaccines. Here, we...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0991

    authors: Curti A,Parenza M,Colombo MP

    更新日期:2003-01-15 00:00:00